Edges in Network
| Network | GSE12093_top500tf - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ASCL2 |
| Upstream (Parents) |
|---|
| (<<) PPARG → ASCL2 |
| (<<) IKZF1 → ASCL2 |
| (<<) MAF → ASCL2 |
| (<<) NKX3-1 → ASCL2 |
| (<<) POU4F2 → ASCL2 |
| (<<) CREB3L1 → ASCL2 |
| (<<) YY1 → ASCL2 |
| (<<) NR2F6 → ASCL2 |
| (<<) KLF1 → ASCL2 |
| (<<) ZNF192 → ASCL2 |
| (<<) NEUROD2 → ASCL2 |
| (<<) NR2C2 → ASCL2 |
| (<<) SCRT1 → ASCL2 |
| Downstream (Children) |
|---|
| ASCL2 → NR5A2 (>>) |
| ASCL2 → ZFP36L1 (>>) |
| ASCL2 → NFKB2 (>>) |
| ASCL2 → TLX3 (>>) |
| ASCL2 → MYF5 (>>) |
| ASCL2 → STAT1 (>>) |
| ASCL2 → RUNX1 (>>) |
| ASCL2 → MEF2A (>>) |
| ASCL2 → RBPJL (>>) |
| ASCL2 → MEF2C (>>) |
| ASCL2 → FOXO4 (>>) |
| ASCL2 → SMAD5 (>>) |
| ASCL2 → POU5F1B (>>) |
| ASCL2 → RORB (>>) |
| ASCL2 → EPAS1 (>>) |
| ASCL2 → FOXD2 (>>) |
| ASCL2 → HMGA2 (>>) |
